What is NDC 68180-354?

68180-354 is the product NDC for Ranolazine, Ranolazine 500 mg/1 tablet, film coated, extended release, listed with the FDA by Lupin Pharmaceuticals, Inc..

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranolazine?

53 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranolazine NDC 68180-354 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-354Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0354Add the package segment from the table below.

Product information

Brand name (proprietary): Ranolazine
Generic name (nonproprietary): ranolazine
Active ingredients: Ranolazine — 500 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201046
Marketing start: Feb 27, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 68180-354_e5f38101-deda-4a41-8c51-76edce7df3e8SPL ID e5f38101-deda-4a41-8c51-76edce7df3e8SPL set ID 595821d7-1fbf-49a5-9c62-d78f27af39b4RxCUI 616749, 728231UNII A6IEZ5M406UPC 0368180354079, 0368180355076
Pharmacologic class: Anti-anginal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Dec 8, 2023.

Indications (excerpt from the label)

Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 ) Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-354

What is NDC 68180-354?: 68180-354 is the product NDC for Ranolazine, Ranolazine 500 mg/1 tablet, film coated, extended release, listed with the FDA by Lupin Pharmaceuticals, Inc..
What drug is associated with this NDC?: Ranolazine.
What is the active ingredient?: Ranolazine.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranolazine?: 53 other product NDCs are listed under this name. See all Ranolazine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranolazine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranolazine	Ranolazine 1000 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-056	60290-0056-0160290-0056-03
Ranolazine	Ranolazine 500 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-055	60290-0055-0160290-0055-03
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-759	13668-0759-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-760	13668-0760-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-151	90096-0151-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-152	90096-0152-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-423	77771-0423-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-424	77771-0424-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-971	71610-0971-42
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	A2A Integrated Pharmaceuticals	73141-022	73141-0022-02

All 54 Ranolazine NDCs

Other NDCs under ANDA 201046

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201046
Product	Strength	Form · route	Labeler	Product NDC
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-355